STAR2024-01-012024-03-31 STAR2024-01-012024-03-31 STAR2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member STAR2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member STAR2024-03-31 STAR2024-01-012024-03-31in-bse-fin:OneReportableSegmentRevenue01Member STAR2024-01-012024-03-31in-bse-fin:OneReportableSegmentRevenue02Member STAR2024-01-012024-03-31in-bse-fin:FourReportableSegmentRevenue01Member STAR2024-01-012024-03-31in-bse-fin:FourReportableSegmentRevenue02Member STAR2024-01-012024-03-31in-bse-fin:OneReportableSegmentResults01Member STAR2024-01-012024-03-31in-bse-fin:OneReportableSegmentResults02Member STAR2024-01-012024-03-31in-bse-fin:FourReportableSegmentResults01Member STAR2024-01-012024-03-31in-bse-fin:FourReportableSegmentResults02Member STAR2024-01-012024-03-31in-bse-fin:OneReportableSegmentAssets01Member STAR2024-01-012024-03-31in-bse-fin:OneReportableSegmentAssets02Member STAR2024-01-012024-03-31in-bse-fin:OneReportableSegmentLiabilities01Member STAR2024-03-31in-bse-fin:OneReportableSegmentLiabilities01Member STAR2024-01-012024-03-31in-bse-fin:OneReportableSegmentLiabilities02Member STAR2024-03-31in-bse-fin:OneReportableSegmentLiabilities02Member STAR2024-01-012024-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member STAR2024-01-012024-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member STAR2024-01-012024-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member STAR2024-01-012024-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532531 STAR NOTLISTED Strides Pharma Science Limited Equity 2023-04-01 2024-03-31 2024-05-22 2024-05-14 INR Millions Yearly 11:30:00 13:30:00 2024-05-22 2024-05-22 true Cash Flow Indirect Declaration of unmodified opinion Multi segment 2024-01-01 2024-03-31 Audited Consolidated 10840350000.00 -135460000.00 10704890000.00 3538360000.00 1126420000.00 -502530000.00 1991690000.00 801560000.00 497600000.00 2389070000.00 9842170000.00 862720000.00 -80710000.00 782010000.00 124850000.00 67660000.00 192510000.00 0.00 589500000.00 720000.00 0.00 720000.00 -485790000.00 104430000.00 -533090000.00 -428660000.00 181750000.00 -77320000.00 -373490000.00 -55170000.00 919000000.00 10 1.97 1.97 0.01 0.01 1.98 1.98 Multi segment 2023-04-01 2024-03-31 Audited Consolidated 40511240000.00 397010000.00 40908250000.00 13411130000.00 2834490000.00 159430000.00 7511250000.00 3144450000.00 2206830000.00 9162300000.00 38429880000.00 2478370000.00 -1890450000.00 587920000.00 373120000.00 -57220000.00 315900000.00 0.00 272020000.00 542200000.00 0.00 542200000.00 -1757360000.00 -943140000.00 -547040000.00 -1490180000.00 -706140000.00 -237000000.00 -1246840000.00 -243340000.00 919000000.00 10 20336630000.00 -13.72 -13.72 5.96 5.95 -7.76 -7.77 Other Expenses 2389070000.00 Other Expenses 9162300000.00 -538570000.00 8786670000.00 798790000.00 118990000.00 5294110000.00 4451000000.00 820150000.00 0.00 1892970000.00 76310000.00 0.00 500000000.00 1916670000.00 2492980000.00 2673460000.00 1378440000.00 28707560000.00 11262400000.00 1057580000.00 11418740000.00 1610200000.00 301460000.00 127340000.00 1195070000.00 15710390000.00 0.00 2717200000.00 29689990000.00 0.00 0.00 58397550000.00 919000000.00 20336630000.00 21255630000.00 20717060000.00 6714990000.00 0.00 853160000.00 7568150000.00 916300000.00 403450000.00 0.00 0.00 8887900000.00 17430260000.00 8515910000.00 1037840000.00 26984010000.00 689170000.00 715250000.00 404160000.00 0.00 28792590000.00 0.00 0.00 37680490000.00 58397550000.00 Bio-pharmaceutical business 0.00 Pharmaceutical business 10840350000.00 Bio-pharmaceutical business 0.00 Pharmaceutical business 40511240000.00 10840350000.00 40511240000.00 0.00 0.00 10840350000.00 40511240000.00 Bio-pharmaceutical business -137280000.00 Pharmaceutical business 1235060000.00 Bio-pharmaceutical business -1219350000.00 Pharmaceutical business 3194360000.00 1097780000.00 1975010000.00 801560000.00 3144450000.00 0.00 0.00 296220000.00 -1169440000.00 Bio-pharmaceutical business 1809930000.00 Pharmaceutical business 56587620000.00 58397550000.00 0.00 58397550000.00 Bio-pharmaceutical business 0.00 Pharmaceutical business 37680490000.00 37680490000.00 0.00 37680490000.00 3144450000.00 307040000.00 390900000.00 0.00 0.00 0.00 0.00 0.00 0.00 -1485260000.00 0.00 0.00 0.00 2206830000.00 0.00 174910000.00 0.00 0.00 0.00 208880000.00 0.00 304260000.00 15860000.00 0.00 0.00 -57060000.00 0.00 1577970000.00 0.00 6180260000.00 6768180000.00 0.00 0.00 0.00 -242470000.00 0.00 7010650000.00 0.00 0.00 0.00 151190000.00 0.00 0.00 0.00 0.00 888060000.00 1181510000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 541690000.00 0.00 0.00 0.00 0.00 152710000.00 0.00 -668880000.00 0.00 -1502500000.00 0.00 0.00 13740000.00 513000000.00 0.00 0.00 0.00 0.00 3497640000.00 7342200000.00 0.00 558340000.00 135170000.00 2921900000.00 0.00 0.00 -6933230000.00 -1425080000.00 270000.00 -1424810000.00 3035010000.00 1610200000.00 Items that will not be reclassified to statement of profit and loss -565460000.00 Items that will not be reclassified to statement of profit and loss -578980000.00 -565460000.00 -578980000.00 -19120000.00 -19370000.00 Items that may be reclassified to statement of profit and loss 19350000.00 Items that may be reclassified to statement of profit and loss 30420000.00 19350000.00 30420000.00 6100000.00 17850000.00